Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
475
-
Total 13F shares, excl. options
-
57.7M
-
Shares change
-
+659K
-
Total reported value, excl. options
-
$6.95B
-
Value change
-
+$71.7M
-
Put/Call ratio
-
2.78
-
Number of buys
-
231
-
Number of sells
-
-219
-
Price
-
$120.42
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2024
562 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q1 2024.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 475 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.7M shares
.
Largest 10 shareholders include BlackRock Inc. (7.07M shares), VANGUARD GROUP INC (6.45M shares), STATE STREET CORP (2.46M shares), LSV ASSET MANAGEMENT (2.38M shares), JPMORGAN CHASE & CO (1.49M shares), Polaris Capital Management, LLC (1.43M shares), Capital World Investors (1.43M shares), AMERIPRISE FINANCIAL INC (1.37M shares), Pacer Advisors, Inc. (1.29M shares), and RENAISSANCE TECHNOLOGIES LLC (1.17M shares).
This table shows the top 475 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.